N-α-Boc-N-δ-Boc-L-ornithine is a protected, naturally occurring amino acid derivative in which the basic side chain of L-ornithine is the target for orthogonal protection, yielding an Nα,Nδ-doubly Boc-protected ornithine building block for peptide-related synthesis. The molecule contains a free carboxyl group and an amino acid backbone bearing two tert-butoxycarbonyl (Boc) protecting groups on the α-amino and δ-amino functionalities, while the side-chain carbon skeleton remains intact to present the protected guanidinium-free primary amine equivalent for controlled deprotection. In synthetic workflows, the dual Boc protection pattern supports stepwise chemoselective amino-group unmasking and provides a defined, protected ornithine residue for preparing peptides, peptidomimetics, and related amino acid conjugates where selective access to the side-chain amine is required.
CAT No: CP08716
CAS No:109425-55-0
Synonyms/Alias:Fmoc-Orn(Boc)-OH;109425-55-0;Nalpha-Fmoc-Ndelta-Boc-L-ornithine;Ndelta-Boc-Nalpha-Fmoc-L-ornithine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((tert-butoxycarbonyl)amino)pentanoic acid;(2S)-5-{[(tert-butoxy)carbonyl]amino}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanoic acid;Fmoc-L-Orn(Boc)-OH;MFCD00065668;(2S)-5-(((tert-butoxy)carbonyl)amino)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)pentanoic acid;Fmoc-Orn-(N-Boc);Fmoc-(Nd-Boc)-L-ornithine;N5-Boc-N2-Fmoc-L-ornithine;SCHEMBL1638340;DTXSID00373246;N-alpha-Fmoc-Ndelta-Boc-L-ornithine;AKOS015924224;CS-W011572;FF47350;HY-W010856;(2S)-5-[(tert-butoxycarbonyl)amino]-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pentanoic acid;AC-32121;AS-17433;DB-030115;B4184;Fmoc-Orn(Boc)-OH, >=96.0% (HPLC);EN300-262356;I10309;M03436;S-109425-55-0;N-alpha-Fluorenylmethoxycarbonyl-N-delta-tert-butoxycarbonyl-L-ornithine;(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(tert-butoxycarbonylamino)pentanoic acid;(S)-5-tert-Butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)-pentanoic acid;5-t-butoxycarbonylamino-(2S)-(9H-fluoren-9-ylmethoxycarbonyl amino)-pentanoic acid;5-t-butoxycarbonylamino-(2S)-(9H-fluoren-9-ylmethoxycarbonylamino)-pentanoic acid;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-delta-t-butyl-oxycarbonyl-L-ornithine;Ndelta-(tert-Butoxycarbonyl)-Nalpha-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-ornithine;882-625-6;
N-α-Boc-N-δ-Boc-L-ornithine is a protected L-ornithine derivative bearing two orthogonal tert-butoxycarbonyl (Boc) protecting groups on the α-amino and δ-amino functionalities, with the side chain terminating in a primary amine typical of ornithine. The molecule retains a stereogenic center at the α-carbon, enabling stereochemically defined incorporation into peptide and peptidomimetic sequences after deprotection and coupling. The dual Boc strategy modulates nucleophilicity of both amino groups, improves handling stability, and supports controlled sequential deprotection to access either the α- or side-chain amine for downstream functionalization. The presence of protected amines and a carboxylic acid (or acid-equivalent form depending on the supplier specification) makes the compound a practical chiral amino acid intermediate for peptide building block preparation and for manufacturing routes that require orthogonally protected diamino acid chemistry.
1. Peptide Synthesis
N-α-Boc-N-δ-Boc-L-ornithine serves as a protected diamino acid building block for solid-phase or solution-phase peptide synthesis where ornithine residues are required with side-chain amino functionality preserved for later steps. The α-Boc and δ-Boc groups suppress undesired side reactions during peptide coupling, while the defined L-configuration supports stereochemical fidelity at the residue level. Selective Boc removal can expose the α-amine for iterative coupling or reveal the side-chain amine for orthogonal extension, enabling controlled construction of polycationic peptides and ornithine-containing motifs. The resulting peptide analogs can be further elaborated into cationic scaffolds, stapled structures, or sequence-defined intermediates that depend on precise placement of the side-chain amine.
2. Side-Chain Functionalization
N-α-Boc-N-δ-Boc-L-ornithine is applied in synthetic organic chemistry and chemical biology workflows that require stepwise side-chain derivatization of ornithine while maintaining orthogonal protection. The protected δ-amine can be unveiled under Boc-deprotection conditions to generate a nucleophilic primary amine suitable for amide formation, sulfonamide synthesis, carbamate formation, or linkage to electrophilic tags. The α-Boc protection can remain intact to direct functionalization toward the side chain, supporting regioselective modification of diamino acid frameworks used in molecular recognition studies and conjugation chemistry. Downstream derivatives generated from the exposed ornithine amine can serve as intermediates for labeled probes, affinity handles, or charge-tunable building blocks for structure-driven molecular design.
3. Bioconjugation Chemistry
N-α-Boc-N-δ-Boc-L-ornithine supports bioconjugation and biomolecule modification strategies where controlled installation of primary amine functionality is required for coupling to activated carboxylates, activated esters, isothiocyanates, or aldehyde-derived linkers. The orthogonally protected amino groups help manage chemoselectivity by masking one amine during conjugation while enabling selective deprotection to expose the intended attachment site. The ornithine side chain contributes a cationic, protonatable handle that can influence solubility and binding behavior of conjugates used in biochemical research and analytical workflows. The protected amino acid intermediate can be converted into conjugation-ready amine-bearing derivatives that maintain stereochemical definition and support reproducible downstream labeling or immobilization.
4. Chiral Amino Acid Intermediate
N-α-Boc-N-δ-Boc-L-ornithine functions as a chiral amino acid intermediate for stereochemically defined synthesis of protected ornithine derivatives, including intermediates used in peptidomimetic construction and medicinal chemistry fragment elaboration. The dual Boc protection provides a stable platform for handling and transport during multi-step synthesis, while the L-configuration at the α-carbon ensures consistent stereochemical outcomes in subsequent coupling or functional group transformations. Sequential deprotection and re-protection strategies can be employed to access either the α- or δ-amino group for controlled derivatization, enabling tailored substitution patterns on diamino acid scaffolds. The compound's protected diamine architecture aligns with process chemistry needs for orthogonal protection management in fine chemical synthesis and specialty intermediate production.
5. Pharmaceutical Manufacturing
N-α-Boc-N-δ-Boc-L-ornithine is suitable for pharmaceutical intermediate preparation where ornithine-derived fragments or peptide-like intermediates require robust protection of multiple amines during manufacturing-scale synthesis. The Boc groups provide protection against premature amide or urea formation, supporting cleaner coupling steps and reducing formation of side products associated with free diamine reactivity. The ability to selectively unmask the α- or δ-amino functionality supports downstream route design for intermediate diversification, including conversion to activated derivatives for subsequent assembly into larger molecules. The compound's defined stereochemistry and orthogonal protection pattern make it compatible with iterative synthetic planning used in chemical manufacturing of amino acid-derived intermediates and process-scale peptide building blocks.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.